Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP) (Q77933591)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 July 1999

Language	Label	Description	Also known as
English	Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP)	scientific article published on 01 July 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

viral hepatitis

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

V Carreño

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

P Marcellin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

S Hadziyannis

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J Salmerón

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Diago

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

G E Kitis

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

I Vafiadis

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

S W Schalm

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

F Zahm

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

F Manzarbeitia

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

F J Jiménez

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J A Quiroga

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

0 references

publication date

1 July 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

277-282

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative study of three doses of interferon-alpha 2a in chronic active hepatitis B. The International Hepatitis Trial Group.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

Repeated courses of alpha-interferon for treatment of chronic hepatitis type B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation between treatment efficacy and cumulative dose of alpha interferon in chronic hepatitis B. European Concerted Action on Viral Hepatitis (Eurohep)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of chronic hepatitis B patients treated with interferon alfa

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

The dynamics of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

Experience with lamivudine against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical experience with famciclovir against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300117

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.510300117

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385667%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77933591&oldid=1679925762"